Abiraterone acetate (ZYTIGA) should be considered a standard of care for newly diagnosed, metastatic, non-castrate prostate cancer, as should docetaxel (Taxotere), according to a new clinical practice guideline from ASCO.
Nocturia affects more than 40 million adults in the United States yet only 1.5 million are receiving treatment. And while this condition is under-recognized, its impact is very real — resulting in $62.5 billion in healthcare costs each year. What steps can you take to ease the burden for patients who suffer from nocturia?
Data from a recent study also indicate that overactive bladder patients discontinue pharmacotherapy long-term despite chronic symptoms.
Until now there has been no large, thorough investigation into the risk of clean intermittent catheterization in patients undergoing repeat injections of onabotulinumtoxinA.
Findings from a cost-effectiveness analysis provide useful information for physicians, patients, and payers about available treatments for lower urinary tract symptoms due to BPH, according to the authors who conducted it.
In this "Practice Matters" column Robert A. Dowling, MD, outlines practice management and health policy sessions to watch for at the 2018 AUA annual meeting in San Francisco.
How can you be sure you’ve selected the best approach for your patients with urologic cancer? As our experts debate developments like MRI fusion biopsy for PCa, HIFU for low-risk prostate cancer, and white light cystoscopy, learn how you can integrate these treatments into your practice.
"Concerns about scope of practice aside, there is no doubt that as the demand for urologic services increases and the number of practicing urologists decreases, we will need to find alternative ways to continue to see and treat our patients," writes Henry Rosevear, MD.
Urologist Henry Rosevear, MD, shares what he's most looking forward to at the AUA annual meeting in San Francisco.
These videos illustrate a robotic solution to the complex problem of very large prostate glands causing severe lower urinary tract symptoms.